Previous Article | Next Article 
Infect Immun, June 1998, p. 2987-2990, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Formation of Ring-Shaped Structures on Erythrocyte Membranes
after Treatment with Botulinolysin, a Thiol-Activated Hemolysin
from Clostridium botulinum
Kachiko
Sekiya,1,*
Hirofumi
Danbara,1
Yutaka
Futaesaku,2
Abdul
Haque,3
Nakaba
Sugimoto,3 and
Morihiro
Matsuda4
Department of Microbiology, School of
Pharmaceutical Sciences, Kitasato University, Minato-ku, Tokyo
108-8641,1
Department of Histology and
Analytical Morphology, School of Allied Health Sciences, Kitasato
University, Sagamihara, Kanagawa 228-8555,2
Department of Bacterial Toxinology, Research Institute for
Microbial Diseases, Osaka University, Yamadaoka, Osaka
565-0871,3 and
College of Nutrition,
Koshien University, 10-1 Momijigaoka, Takarazuka, Hyogo
665-0006,4 Japan
Received 2 December 1997/Returned for modification 12 January
1998/Accepted 5 March 1998
 |
ABSTRACT |
Damage to erythrocyte membranes by botulinolysin (BLY) was studied
by electron microscopy, which revealed ring-shaped structures with
inner diameters and widths of approximately 32 and 6.7 nm, respectively. BLY bound to membranes at 0°C, but subsequent treatment with glutaraldehyde prevented ring formation during further incubation at 37°C. Zn2+ ions inhibited ring formation but not
binding of BLY to membranes.
 |
TEXT |
Botulinolysin (BLY) is an
oxygen-labile hemolysin produced by Clostridium botulinum
(1-4, 13) that is a member of the family of thiol-activated
cytotoxins (1-4, 32, 34). This family consists, at present,
of about 20 different toxins that are produced by four genera of
gram-positive bacteria, namely, Streptococcus, Bacillus, Clostridium, and Listeria
(1-4, 8, 10, 27, 34). Formation of ring-shaped and
arc-shaped structures has been observed under the electron microscope
on erythrocyte membranes that have been treated with some of these
toxins (5, 11, 12, 20, 24, 29). Members of our group
reported a molecular model for the formation of rings on erythrocyte
membranes by streptolysin O (SLO) from Streptococcus
pyogenes (29). The various toxins bind cholesterol and
their cytolytic activity is inhibited by treatment with cholesterol
(12, 15, 16, 20, 31). Recently, the three-dimensional
structure of perfringolysin O (PFO;
-toxin), another thiol-activated
cytolysin, was reported, and the fine structures of the
cholesterol-binding site and of the region required for formation of
oligomers were described (28). Thiol-activated toxins have
potent lytic activity against mammalian cells and other eukaryotic
cells (3, 35). Purified BLY also has a lethal effect on mice
and a cytotoxic effect on Vero cells (13, 33). Thus,
membrane damage by thiol-activated toxins might play an important role
in the pathogenesis (9) of various diseases if the causative
microorganisms produce thiol-activated cytolysins. We are interested in
the similarities and differences between toxins from different genera,
and we are attempting to clarify the characteristics of various toxins.
In this study, we examined the fine-structural changes in erythrocyte
membranes induced by BLY, focusing on the formation of ring-shaped
structures, as part of an effort to elucidate the mechanism of membrane
damage by BLY of erythrocyte membranes.
BLY was purified as described by Haque et al., with slight modification
(13). The hemolytic activity of BLY was expressed as the
50% hemolytic dose per microgram of protein. The specific activity of
our preparation of BLY was approximately 1,500 hemolytic units
(HU)/µg of protein with rabbit erythrocytes as the assay material.
Erythrocyte and ghost membranes were prepared from rabbit erythrocytes
by the previously described method, with slight modification (29,
30). Preparations of membranes that had been treated with BLY as
described below were washed with physiological saline (Ohtsuka
Pharmaceutical Co., Tokyo, Japan), fixed with 2.5% glutaraldehyde for
1 min, washed with distilled water (DW; Ohtsuka Pharmaceutical Co.),
and negatively stained with 2% phosphotungstic acid. Specimens were
observed under a transmission electron microscope (Hitachi H-500, JEOL
2000 EX, JEM 1010, or Carl Zeiss CEM-902A).
Sizes and structures of BLY rings on erythrocyte membranes.
Twenty microliters of a 10% suspension of erythrocytes that had been
diluted with physiological saline was mixed with 10 µl of BLY
(170,000 HU/ml) in a test tube. The mixture was incubated at 37°C for
5 min. Then 10 µl of the mixture of lysed erythrocytes was dropped
onto 100 µl of DW on Sealon film (Fuji Film Co., Tokyo, Japan) and
mixed gently with a micropipette. After 30 to 40 min, the membrane
fragments that floated at the air-water interface were mounted on
supporting Butval-98 films (Nissin EM, Tokyo, Japan) on a grid for
electron microscopy. Negative staining of erythrocyte membranes treated
with BLY revealed numerous ring-shaped structures (BLY rings [Fig.
1A]). Semicircular structures were also
observed. The inner diameters of BLY rings were 32 ± 2.4 nm
(n = 50), as determined from radii of semicircular
rings, and the rings themselves were 6.7 ± 0.6 nm
(n = 50) wide, as observed in the case of SLO rings.
The dimensions of the rings, together with those of rings formed by
other toxins, are summarized in Table 1.
Higher magnification revealed a double-layered structure (29,
30) (Fig. 1B). Crown-shaped structures (29) were also observed on rings at folded edges of erythrocyte membranes (data not
shown).

View larger version (132K):
[in this window]
[in a new window]
|
FIG. 1.
Electron micrographs of rings formed on an erythrocyte
membrane that had been treated with BLY at 37°C for 5 min. Note rings
with pores in panel A and double-layered structures indicated by the
arrow in panel B.
|
|
Effects of temperature on binding and formation of pores by BLY on
erythrocyte membranes.
Ghost membranes were thawed at room
temperature after storage at
80°C. Floating ghost membranes on the
surface of DW were prepared as described previously (23, 29)
and mounted on supporting Butval-98 films on a grid. Purified BLY was
diluted 25-fold with 5 mM Tris-HCl (pH 7.2) that contained 0.85% NaCl
and 5 mM cysteine (Tris NaCl-cysteine buffer). The ghost membranes on
supporting films were treated with 10 µl of diluted BLY (6,800 HU/ml). After the treatment with BLY at room temperature for 3 to 5 min, we observed numerous BLY rings (results resembled those in Fig.
1A). By contrast, we observed no ring-shaped structures on ghost
membranes treated with BLY at 0°C (data not shown). Binding of BLY to
ghost membranes was confirmed by immunogold labeling with a pooled
preparation of four mouse monoclonal antibodies against BLY that had
almost the same affinities. For visualization, we used
5-nm-diameter colloidal-gold-conjugated goat antibodies against
mouse immunoglobulin G (Zymed Laboratories Inc., San Francisco,
Calif.) (data not shown). Controls were treated with only
gold-conjugated second antibody, and no gold particles were found on
the membranes. Rings with pores formed on membranes that had been
incubated with BLY at 0°C for 3 to 5 min, washed to remove excess
BLY, and then incubated at 37°C for 1 min (results resembled those in
Fig. 1A).
Effects of glutaraldehyde on pore formation.
When ghost
membranes were treated with BLY at 0°C for 3 to 5 min, fixed with 1%
glutaraldehyde at 0°C for 1 min, and then incubated at 37°C for 1 to 3 min, we observed very few BLY rings on the membranes (data not
shown). However, BLY formed numerous rings with pores on membranes that
had been fixed with glutaraldehyde for 1 min before exposure to BLY at
room temperature for 5 min (results resembled those in Fig. 1A).
Effects of Zn2+ ions on pore formation.
When the
preparation of BLY was diluted with Tris NaCl-cysteine buffer that
contained 10 mM Zn2+ ions and applied to membranes at room
temperature for 5 min, no BLY rings were observed. However, gold
particles were found on these membranes after immunogold labeling (data
not shown).
We confirmed that the binding of BLY to membranes was temperature
independent, as it is in the two-step theory (14, 26, 30)
proposed previously to explain the formation of SLO rings on
erythrocyte membranes. BLY molecules bound to membranes at 0°C and
then oligomerized to form rings with an increase in incubation temperature. The higher fluidity of lipid bilayers at higher
temperatures might allow BLY to move on erythrocyte membranes,
oligomerize, and finally form pores. When erythrocyte membranes with
bound BLY were fixed with glutaraldehyde, no BLY rings were observed, even after incubation at 37°C. The mobility of BLY molecules on membranes might be affected by glutaraldehyde, which might denature BLY
or form bridges between BLY molecules or between BLY and other components of the membrane. BLY did, however, form rings with pores
when membranes were treated with glutaraldehyde prior to incubation
with BLY. Proteins or amine residues in erythrocyte membranes might not
be involved directly in the formation of BLY rings.
Sekiya et al. proposed a double-layer SLO ring model composed of about
50 SLO molecules (
29). Morgan et al. (
21,
22)
reported that pneumolysin forms single-layer rings composed of
40 to 50 subunits, with each subunit having four domains. PFO
rings also seem to
be composed of about 50 PFO molecules (
25).
Although there
is some discrepancy among the models, the number
of molecules in each
ring is almost the same. The molecular weight
of BLY is 58,000 (
13) and is close to those estimated for SLO
(53,000 and
60,000 [
3,
17]). Since the diameter of BLY rings,
47 nm, is larger than that of SLO rings, 36 nm (
5,
29), BLY
rings might be composed of more than 50 BLY molecules.
Zn
2+ ions at 5 to 10 mM prevented pore formation by BLY, as
well as by PFO (
18), but binding of BLY to membranes was
unaffected.
Ca
2+, Co
2+, and Mg
2+
ions also blocked pore formation (data not shown). Menestrina
et al.
(
18) reported that lysis by PFO was inhibited by divalent
cations in the order, from greatest to least inhibition, of
Zn
2+ > Ca
2+ > Mg
2+. They proposed
that inhibition by Zn
2+ ions might be due, at least in
part, to the promotion and maintenance
of pore closure. Once BLY has
formed a semicircular (arc) structure
on a membrane, the arc-shaped
structure gradually increases in
length to form a C shape or a ring.
When the tension within the
cell membrane on the concave side of the
ring becomes greater
than the repulsive force, the inside of the ring
opens as a pore.
It is unclear how Zn
2+ ions and other
divalent cations might prevent pore formation
by BLY after BLY has
bound to the membrane. The effects of metal
ions on cytolytic toxins
might provide a key to the mechanism
of pore formation.
The results are summarized in Table
2.
 |
ACKNOWLEDGMENTS |
This study was supported in part by Grants-in-Aid for Scientific
Research (06670303 and 08557002) from the Ministry of Education, Science and Culture of Japan and by a Grant-in-Aid for Scientific Research (Project-11) from the School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, School of Pharmaceutical Sciences, Kitasato University, Minato-ku, Tokyo 108-8641, Japan. Phone: 81-3444-6161. Fax:
81-3444-4831. E-mail:
sekiyak{at}platinum.pharm.kitasato-u.ac.jp.
Editor: J. T. Barbieri
 |
REFERENCES |
| 1.
|
Alouf, J. E.
1977.
Cell membranes and cytolytic bacterial toxins, p. 219-270.
In
P. Cuatrecasas (ed.), Receptors and recognition, series B, vol. 1. The specificity and action of animal, bacterial and plant toxins. Chapman and Hall, London, England.
|
| 2.
|
Alouf, J. E.
1980.
Streptococcal toxins (streptolysin O, streptolysin S and erythrogenic toxin).
Pharmacol. Ther.
11:661-717[Medline].
|
| 3.
|
Alouf, J. E., and C. Geoffroy.
1991.
The family of the antigenically related cholesterol-binding ('sulfhydryl activated') cytolytic toxins, p. 147-186.
In
J. E. Alouf, and J. H. Freer (ed.), Source book of bacterial protein toxins. Academic Press, London, England.
|
| 4.
|
Bernheimer, A. W., and B. Rudy.
1986.
Interactions between membranes and cytolytic peptides.
Biochim. Biophys. Acta
864:123-141[Medline].
|
| 5.
|
Bhakdi, S.,
M. Roth,
A. Sziegoleit, and J. Tranum-Jensen.
1984.
Isolation and identification of two hemolytic forms of streptolysin-O.
Infect. Immun.
46:394-400[Abstract/Free Full Text].
|
| 6.
|
Bhakdi, S.,
J. Tranum-Jensen, and A. Sziegoleit.
1985.
Mechanism of membrane damage by streptolysin-O.
Infect. Immun.
47:52-60[Abstract/Free Full Text].
|
| 7.
|
Bhakdi, S., and J. Tranum-Jensen.
1988.
Damage to cell membranes by pore-forming bacterial cytolysins.
Prog. Allergy
40:1-43[Medline].
|
| 8.
|
Bhakdi, S.,
U. Weller,
I. Walev,
E. Martin,
D. Jonas, and M. Palmer.
1993.
A guide to the use of pore-forming toxins for controlled permeabilization of cell membranes.
Med. Microbiol. Immunol.
182:167-175[Medline].
|
| 9.
|
Bhakdi, S.,
F. Grimminger,
N. Suttorp,
D. Walmrath, and W. Seeger.
1994.
Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection.
Med. Microbiol. Immunol.
183:119-144[Medline].
|
| 10.
|
Boulnois, G. J.,
J. C. Paton,
T. J. Mitchell, and P. W. Andrew.
1991.
Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae.
Mol. Microbiol.
5:2611-2616[Medline].
|
| 11.
|
Cowell, J. L.,
K.-S. Kim, and A. W. Bernheimer.
1978.
Alteration by cereolysin of the structure of cholesterol-containing membranes.
Biochim. Biophys. Acta
507:230-241[Medline].
|
| 12.
|
Duncan, J. L., and R. Schlegel.
1975.
Effect of streptolysin O on erythrocyte membranes, liposomes, and lipid dispersions. A protein-cholesterol interaction.
J. Cell Biol.
67:160-173[Abstract/Free Full Text].
|
| 13.
|
Haque, A.,
N. Sugimoto,
Y. Horiguchi,
T. Okabe,
T. Miyata,
S. Iwanaga, and M. Matsuda.
1992.
Production, purification, and characterization of botulinolysin, a thiol-activated hemolysin of Clostridium botulinum.
Infect. Immun.
60:71-78[Abstract/Free Full Text].
|
| 14.
|
Hugo, F.,
J. Reichwein,
M. Arvand,
S. Krämer, and S. Bhakdi.
1986.
Use of a monoclonal antibody to determine the mode of transmembrane pore formation by streptolysin O.
Infect. Immun.
54:641-645[Abstract/Free Full Text].
|
| 15.
|
Jacobs, A. A. C.,
P. L. W. Loeffen,
A. J. G. van den Berg, and P. K. Storm.
1994.
Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis.
Infect. Immun.
62:1742-1748[Abstract/Free Full Text].
|
| 16.
|
Johnson, M. K.,
C. Geoffroy, and J. E. Alouf.
1980.
Binding of cholesterol by sulfhydryl-activated cytolysins.
Infect. Immun.
27:97-101[Abstract/Free Full Text].
|
| 17.
|
Kehoe, M. A.,
L. Miller,
J. A. Walker, and G. J. Boulnois.
1987.
Nucleotide sequence of the streptolysin O (SLO) gene: structural homologies between SLO and other membrane-damaging, thiol-activated toxins.
Infect. Immun.
55:3228-3232[Abstract/Free Full Text].
|
| 18.
|
Menestrina, G.,
C. L. Bashford, and C. A. Pasternak.
1990.
Pore-forming toxins: experiments with S. aureus -toxin, C. perfringens -toxin and E. coli haemolysin in lipid bilayers, liposomes and intact cells.
Toxicon
28:477-491[Medline].
|
| 19.
|
Mitsui, K.,
T. Sekiya,
Y. Nozawa, and J. Hase.
1979.
Alteration of human erythrocyte plasma membranes by perfringolysin O as revealed by freeze-fracture electron microscopy.
Biochim. Biophys. Acta
554:68-75[Medline].
|
| 20.
|
Mitsui, K.,
T. Sekiya,
S. Okamura,
Y. Nozawa, and J. Hase.
1979.
Ring formation of perfringolysin O as revealed by negative stain electron microscopy.
Biochim. Biophys. Acta
558:307-313[Medline].
|
| 21.
|
Morgan, P. J.,
S. C. Hyman,
A. J. Rowe,
T. J. Mitchell,
P. W. Andrew, and H. R. Saibil.
1995.
Subunit organization and symmetry of pore-forming, oligomeric pneumolysin.
FEBS Lett.
371:77-80[Medline].
|
| 22.
|
Morgan, P. J.,
S. C. Hyman,
O. Byron,
P. W. Andrew,
T. J. Mitchell, and A. J. Rowe.
1994.
Modeling the bacterial protein toxin, pneumolysin, in its monomeric and oligomeric form.
J. Biol. Chem.
269:25315-25320[Abstract/Free Full Text].
|
| 23.
|
Nicolson, G. L., and S. J. Singer.
1971.
Ferritin-conjugated plant agglutinins as specific saccharide stains for electron microscopy: application to saccharide bound to cell membrane.
Proc. Natl. Acad. Sci. USA
68:942-945[Abstract/Free Full Text].
|
| 24.
|
Niedermeyer, W.
1985.
Interaction of streptolysin-O with biomembranes: kinetic and morphological studies on erythrocyte membranes.
Toxicon
23:425-439[Medline].
|
| 25.
|
Olofsson, A.,
H. Hebert, and M. Thelestam.
1993.
The projection structure of perfringolysin O.
FEBS Lett.
319:125-127[Medline].
|
| 26.
|
Palmer, M.,
A. Valeva,
M. Kehoe, and S. Bhakdi.
1995.
Kinetics of streptolysin O self-assembly.
Eur. J. Biochem.
231:388-395[Medline].
|
| 27.
|
Parrisius, J.,
S. Bhakdi,
M. Roth,
J. Tranum-Jensen,
W. Goebel, and H. P. R. Seeliger.
1986.
Production of listeriolysin by beta-hemolytic strains of Listeria monocytogenes.
Infect. Immun.
51:314-319[Abstract/Free Full Text].
|
| 28.
|
Rossjohn, J.,
S. C. Feil,
W. J. McKinstry,
R. K. Tweten, and M. W. Parker.
1997.
Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form.
Cell
89:685-692[Medline].
|
| 29.
|
Sekiya, K.,
R. Satoh,
H. Danbara, and Y. Futaesaku.
1993.
A ring-shaped structure with a crown formed by streptolysin O on the erythrocyte membrane.
J. Bacteriol.
175:5953-5961[Abstract/Free Full Text].
|
| 30.
|
Sekiya, K.,
H. Danbara,
K. Yase, and Y. Futaesaku.
1996.
Electron microscopic evaluation of a two-step theory of pore formation by streptolysin O.
J. Bacteriol.
178:6998-7002[Abstract/Free Full Text].
|
| 31.
|
Shany, S.,
A. W. Bernheimer,
P. S. Grushoff, and K.-S. Kim.
1974.
Evidence for membrane cholesterol as the common binding site for cereolysin, streptolysin O and saponin.
Mol. Cell. Biochem.
3:179-186[Medline].
|
| 32.
|
Smyth, C. J., and J. L. Duncan.
1978.
Thiol-activated (oxygen-labile) cytolysins, p. 129-183.
In
J. Jejaszewicz, and T. Wadstrom (ed.), Bacterial toxins and cell membranes. Academic Press, London, England.
|
| 33.
|
Sugimoto, N.,
A. Haque,
Y. Horiguchi, and M. Matsuda.
1997.
Botulinolysin, a thiol-activated hemolysin produced by Clostridium botulinum, inhibits endothelium-dependent relaxation of rat aortic ring.
Toxicon
35:1011-1023[Medline].
|
| 34.
|
Tweten, R. K.
1995.
Pore-forming toxins of gram-positive bacteria, p. 207-229.
In
J. A. Roth, C. A. Bolin, K. A. Brogden, F. C. Minion, and M. J. Wannemuehler (ed.), Virulence mechanisms of bacterial pathogens, 2nd ed. American Society for Microbiology, Washington, D.C.
|
| 35.
|
Walev, I.,
M. Palmer,
A. Valeva,
U. Weller, and S. Bhakdi.
1995.
Binding, oligomerization, and pore formation by streptolysin O in erythrocytes and fibroblast membranes: detection of nonlytic polymers.
Infect. Immun.
63:1188-1194[Abstract].
|
Infect Immun, June 1998, p. 2987-2990, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.